Biogen agreed to acquire Apellis Pharmaceuticals for approximately $5.6 billion, expanding its portfolio in immunology and rare-disease medicines.
Source link
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion
Date:
More like thisRelated
WNBA’s future is bright, but will Cathy Engelbert be there to lead it?
In the darkest days of the past 12 months,...
Trump flew from Turkey on older Air Force One after credible threat from Iran and its proxies
President Trump departed the NATO...
Flash flood warning issued for southwestern McKinley County
MCKINLEY COUNTY, N.M. (KRQE) – The National Weather Service has...
Taylor Farms Called White House to Try to Delay Cyclospora Recall
Officials became convinced by the Food and Drug Administration’s...